EVD+ (n = 31) | EVD− (n = 25) | P value | |
---|---|---|---|
Agea | 59.0 ± 13.4 | 56.7 ± 12.5 | 0.60 |
Female sex | 24 (77.4%) | 12 (48.0%) | 0.022 |
Admission mFa | 3.6 ± 0.7 | 2.3 ± 1.1 | < 0.001 |
Admission HHa | 3.5 ± 1.3 | 1.8 ± 0.9 | < 0.001 |
Admission GCS | 9 (5–14) | 15 (14–15) | < 0.001 |
Admission WFNS | 4 (2–5) | 1 (1–2) | < 0.001 |
Hydrocephalus | 31 (100.0%) | 8 (32.0%) | < 0.001 |
Aneurysm treatment | 0.88 | ||
Clip | 7 (22.6%) | 7 (28.0%) | |
Coil | 14 (45.2%) | 11 (44.0%) | |
Otherb | 10 (32.3%) | 7 (28.0%) | |
Days from SAH to MRI | 8 (4–16) | 6 (3–11) | 0.23 |
DCI or vasospasm | 22 (71.0%) | 7 (28.0%) | 0.001 |
ICU LOS | 22 (18–30) | 10 (8–14) | < 0.001 |
Hospital LOS | 30 (19–46) | 14 (12–17) | < 0.001 |
EVD complications | 20 (64.5%) | N/A | N/A |
Ventriculitis | 3 (9.7%) | N/A | N/A |
Tract hemorrhage | 19 (61.3%) | N/A | N/A |
Overdrainage | 3 (9.7%) | N/A | N/A |
Received VPS among EVD+ | 8 (25.8%) | N/A | N/A |
mRS at discharge | 5 (3–6) | 2 (2–3) | < 0.001 |
mRS at 6 months | 4 (2–6) | 1 (0–2) | 0.001 |